835 results on '"Hellwig, Kerstin"'
Search Results
2. Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose
3. Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
4. Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.
5. Childhood and adolescence factors and multiple sclerosis: results from the German National Cohort (NAKO)
6. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
7. Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
8. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
9. Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany
10. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
11. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany – Baseline characteristics of the POWER@MS1 randomised controlled trial
12. Knowledge and worries on motherhood choice in multiple sclerosis – a cross-sectional study on patient-reported outcome measures
13. Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis
14. Family planning considerations in people with multiple sclerosis
15. Sex effects across the lifespan in women with multiple sclerosis
16. Multiple sclerosis progression: time for a new mechanism-driven framework
17. The Impact of Disease-modifying Therapy on Relapse Risk in Women with Multiple Sclerosis Undergoing Assisted Reproductive Technologies (ART) (S7.005)
18. Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004)
19. Données de grossesses et des enfants de femmes recevant ocrelizumab pour le traitement de la sclérose en plaques : analyse de la plus grande base de données disponible
20. Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
21. Neurologische Infektionen in der Schwangerschaft
22. Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys
23. Neonatal B-Cell Levels and Infant Health in Newborns Potentially Exposed to Anti-CD20 Monoclonal Antibodies During Pregnancy or Lactation.
24. Priority setting: women’s health topics in multiple sclerosis
25. Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry
26. Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis
27. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis
28. Restoring immune tolerance in neuromyelitis optica
29. Restoring immune tolerance in neuromyelitis optica
30. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
31. Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy.
32. Anti-CD20 therapy in pregnancy: Balancing risks and benefits
33. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany – Baseline characteristics of the POWER@MS1 randomised controlled trial
34. Fachübergreifend für gute Impfquoten
35. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
36. Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
37. Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
38. Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry
39. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
40. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
41. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
42. Treatment of Women with Multiple Sclerosis Planning Pregnancy
43. Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis.
44. Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy
45. Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis
46. Pregnancy Registries and Longitudinal Data Collection
47. Fertility and Assisted Reproductive Techniques in Women with MS
48. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
49. Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
50. Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.